<DOC>
	<DOCNO>NCT01357460</DOCNO>
	<brief_summary>Patients advance heterogeneous emphysema due alpha1 antitrypsin deficiency might benefit endoscopic implantation intrabronchial valve .</brief_summary>
	<brief_title>Endoscopic Lung Volume Reduction Patients With Advanced Emphysema Due alpha1 Antitrypsin Deficiency</brief_title>
	<detailed_description>Patient enrollment data acquisition carry prospective basis . It plan enroll total 25 patient advance heterogeneous emphysema due alpha1 antitrypsin deficiency . All patient undergo treatment one study centre Heidelberg . Therapy patient consist implantation intrabronchial valve ( IBV , Spiration , Olympus ) emphysematous destroy lobe .</detailed_description>
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pulmonary Emphysema</mesh_term>
	<mesh_term>Alpha 1-Antitrypsin Deficiency</mesh_term>
	<mesh_term>Alpha 1-Antitrypsin</mesh_term>
	<mesh_term>Protein C Inhibitor</mesh_term>
	<criteria>pulmonary function : FEV1 &lt; 45 % , RV &gt; 150 % , TLC &gt; 100 % alpha1 antitrypsin deficiency ( &lt; 80 mg/dl ) , genotype : PiZS , PiZZ , Pi0/0 heterogenous emphysema homogenous emphysema significant bronchiectasis severe concomitant disease pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Emphysema</keyword>
	<keyword>alpha1 antitrypsin deficiency</keyword>
	<keyword>endoscopic lung volume reduction</keyword>
</DOC>